, /PRNewswire/ -- Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced the additions of two industry-leading artificial intelligence and portfolio management experts to its executive team. The appointments will build Element's leadership as it expands with innovative products and capabilities.
Element is pleased to announce the appointment of , PhD, as Vice President of Artificial Intelligence. Dr. Kia will apply his extensive expertise in Artificial Intelligence within the Life Sciences sector to enhance the value of Element's current and future products.
His role will include optimizing the utility of the comprehensive multi-omic datasets generated by Aviti24. Element is also appointing , PhD, as Vice President of Portfolio Management. Since launching Aviti in 2022, Element has continually released new kits and chemistries, driving innovation and strong differentiation for its products.
Dr. Tian will continue Element's relentless drive, taking charge of program and portfolio management. "The key to Element's success and market growth is our passionate and high-performing team who pushes the boundary of innovations.
The expertise Amirali and Tina bring to Element will expedite our work to provide innovative products for the future of biology," said , CEO, Element Biosciences. "We will continue to redefine what is possible on a sequencer and help labs around the globe shift their science into a higher gear." Amirali brings over.